Cretostimogene Grenadenorepvec
CG3002S
Phase 3 mab active
Quick answer
Cretostimogene Grenadenorepvec for Non Muscle Invasive Bladder Cancer is a Phase 3 program (mab) at CG Oncology with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CG Oncology
- Indication
- Non Muscle Invasive Bladder Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- active